1 Study Coverage 1.1 PVA Foam Embolization Particles Product Introduction 1.2 Market by Type 1.2.1 Global PVA Foam Embolization Particles Market Size Growth Rate by Type 1.2.2 50μm～350μm 1.2.3 350μm～560μm 1.2.4 560μm～710μm 1.2.5 710μm～1000μm 1.2.6 1000μm～1400μm 1.2.7 1400μm～2000μm 1.3 Market by Application 1.3.1 Global PVA Foam Embolization Particles Market Size Growth Rate by Application 1.3.2 Uterine Fibroid Embolization 1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) 1.3.4 Liver Tumor Embolization 1.3.5 Trauma Embolization 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global PVA Foam Embolization Particles Market Size, Estimates and Forecasts 2.1.1 Global PVA Foam Embolization Particles Revenue 2016-2027 2.1.2 Global PVA Foam Embolization Particles Sales 2016-2027 2.2 Global PVA Foam Embolization Particles, Market Size by Region: 2016 VS 2021 VS 2027 2.3 PVA Foam Embolization Particles Historical Market Size by Region (2016-2021) 2.3.1 Global PVA Foam Embolization Particles Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global PVA Foam Embolization Particles Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 PVA Foam Embolization Particles Market Estimates and Projections by Region (2022-2027) 2.4.1 Global PVA Foam Embolization Particles Sales Forecast by Region (2022-2027) 2.4.2 Global PVA Foam Embolization Particles Revenue Forecast by Region (2022-2027) 3 Global PVA Foam Embolization Particles Competitor Landscape by Players 3.1 Global Top PVA Foam Embolization Particles Manufacturers by Sales 3.1.1 Global PVA Foam Embolization Particles Sales by Manufacturer (2016-2021) 3.1.2 Global PVA Foam Embolization Particles Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top PVA Foam Embolization Particles Manufacturers by Revenue 3.2.1 Key PVA Foam Embolization Particles Manufacturers Covered: Ranking by Revenue 3.2.2 Global PVA Foam Embolization Particles Revenue by Manufacturers (2016-2021) 3.2.3 Global PVA Foam Embolization Particles Revenue Share by Manufacturers (2016-2021) 3.2.4 Global PVA Foam Embolization Particles Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by PVA Foam Embolization Particles Revenue in 2020 3.2.6 Global PVA Foam Embolization Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global PVA Foam Embolization Particles Price by Manufacturers 3.4 Global PVA Foam Embolization Particles Manufacturing Base Distribution, Product Types 3.4.1 PVA Foam Embolization Particles Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers PVA Foam Embolization Particles Product Type 3.4.3 Date of International Manufacturers Enter into PVA Foam Embolization Particles Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global PVA Foam Embolization Particles Market Size by Type (2016-2021) 4.1.1 Global PVA Foam Embolization Particles Sales by Type (2016-2021) 4.1.2 Global PVA Foam Embolization Particles Revenue by Type (2016-2021) 4.1.3 PVA Foam Embolization Particles Average Selling Price (ASP) by Type (2016-2021) 4.2 Global PVA Foam Embolization Particles Market Size Forecast by Type (2022-2027) 4.2.1 Global PVA Foam Embolization Particles Sales Forecast by Type (2022-2027) 4.2.2 Global PVA Foam Embolization Particles Revenue Forecast by Type (2022-2027) 4.2.3 PVA Foam Embolization Particles Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global PVA Foam Embolization Particles Market Size by Application (2016-2021) 5.1.1 Global PVA Foam Embolization Particles Sales by Application (2016-2021) 5.1.2 Global PVA Foam Embolization Particles Revenue by Application (2016-2021) 5.1.3 PVA Foam Embolization Particles Price by Application (2016-2021) 5.2 PVA Foam Embolization Particles Market Size Forecast by Application (2022-2027) 5.2.1 Global PVA Foam Embolization Particles Sales Forecast by Application (2022-2027) 5.2.2 Global PVA Foam Embolization Particles Revenue Forecast by Application (2022-2027) 5.2.3 Global PVA Foam Embolization Particles Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States PVA Foam Embolization Particles Market Size YoY Growth 2016-2027 6.1.1 United States PVA Foam Embolization Particles Sales YoY Growth 2016-2027 6.1.2 United States PVA Foam Embolization Particles Revenue YoY Growth 2016-2027 6.1.3 United States PVA Foam Embolization Particles Market Share in Global Market 2016-2027 6.2 United States PVA Foam Embolization Particles Market Size by Players (International and Local Players) 6.2.1 United States Top PVA Foam Embolization Particles Players by Sales (2016-2021) 6.2.2 United States Top PVA Foam Embolization Particles Players by Revenue (2016-2021) 6.3 United States PVA Foam Embolization Particles Historic Market Review by Type (2016-2021) 6.3.1 United States PVA Foam Embolization Particles Sales Market Share by Type (2016-2021) 6.3.2 United States PVA Foam Embolization Particles Revenue Market Share by Type (2016-2021) 6.3.3 United States PVA Foam Embolization Particles Price by Type (2016-2021) 6.4 United States PVA Foam Embolization Particles Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States PVA Foam Embolization Particles Sales Forecast by Type (2022-2027) 6.4.2 United States PVA Foam Embolization Particles Revenue Forecast by Type (2022-2027) 6.4.3 United States PVA Foam Embolization Particles Price Forecast by Type (2022-2027) 6.5 United States PVA Foam Embolization Particles Historic Market Review by Application (2016-2021) 6.5.1 United States PVA Foam Embolization Particles Sales Market Share by Application (2016-2021) 6.5.2 United States PVA Foam Embolization Particles Revenue Market Share by Application (2016-2021) 6.5.3 United States PVA Foam Embolization Particles Price by Application (2016-2021) 6.6 United States PVA Foam Embolization Particles Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States PVA Foam Embolization Particles Sales Forecast by Application (2022-2027) 6.6.2 United States PVA Foam Embolization Particles Revenue Forecast by Application (2022-2027) 6.6.3 United States PVA Foam Embolization Particles Price Forecast by Application (2022-2027) 7 North America 7.1 North America PVA Foam Embolization Particles Market Size YoY Growth 2016-2027 7.2 North America PVA Foam Embolization Particles Market Facts & Figures by Country 7.2.1 North America PVA Foam Embolization Particles Sales by Country (2016-2021) 7.2.2 North America PVA Foam Embolization Particles Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific PVA Foam Embolization Particles Market Size YoY Growth 2016-2027 8.2 Asia Pacific PVA Foam Embolization Particles Market Facts & Figures by Region 8.2.1 Asia Pacific PVA Foam Embolization Particles Sales by Region (2016-2021) 8.2.2 Asia Pacific PVA Foam Embolization Particles Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe PVA Foam Embolization Particles Market Size YoY Growth 2016-2027 9.2 Europe PVA Foam Embolization Particles Market Facts & Figures by Country 9.2.1 Europe PVA Foam Embolization Particles Sales by Country (2016-2021) 9.2.2 Europe PVA Foam Embolization Particles Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America PVA Foam Embolization Particles Market Size YoY Growth 2016-2027 10.2 Latin America PVA Foam Embolization Particles Market Facts & Figures by Country 10.2.1 Latin America PVA Foam Embolization Particles Sales by Country (2016-2021) 10.2.2 Latin America PVA Foam Embolization Particles Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa PVA Foam Embolization Particles Market Size YoY Growth 2016-2027 11.2 Middle East and Africa PVA Foam Embolization Particles Market Facts & Figures by Country 11.2.1 Middle East and Africa PVA Foam Embolization Particles Sales by Country (2016-2021) 11.2.2 Middle East and Africa PVA Foam Embolization Particles Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Cook Medical 12.1.1 Cook Medical Corporation Information 12.1.2 Cook Medical Description and Business Overview 12.1.3 Cook Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Cook Medical PVA Foam Embolization Particles Products Offered 12.1.5 Cook Medical Recent Development 12.2 Sirtex Medical 12.2.1 Sirtex Medical Corporation Information 12.2.2 Sirtex Medical Description and Business Overview 12.2.3 Sirtex Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Sirtex Medical PVA Foam Embolization Particles Products Offered 12.2.5 Sirtex Medical Recent Development 12.3 Merit Medical 12.3.1 Merit Medical Corporation Information 12.3.2 Merit Medical Description and Business Overview 12.3.3 Merit Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Merit Medical PVA Foam Embolization Particles Products Offered 12.3.5 Merit Medical Recent Development 12.4 BTG Medical 12.4.1 BTG Medical Corporation Information 12.4.2 BTG Medical Description and Business Overview 12.4.3 BTG Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2016-2021) 12.4.4 BTG Medical PVA Foam Embolization Particles Products Offered 12.4.5 BTG Medical Recent Development 12.5 Boston Scientific 12.5.1 Boston Scientific Corporation Information 12.5.2 Boston Scientific Description and Business Overview 12.5.3 Boston Scientific PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Boston Scientific PVA Foam Embolization Particles Products Offered 12.5.5 Boston Scientific Recent Development 12.6 Terumo 12.6.1 Terumo Corporation Information 12.6.2 Terumo Description and Business Overview 12.6.3 Terumo PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Terumo PVA Foam Embolization Particles Products Offered 12.6.5 Terumo Recent Development 12.7 HENGRUI Medical 12.7.1 HENGRUI Medical Corporation Information 12.7.2 HENGRUI Medical Description and Business Overview 12.7.3 HENGRUI Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2016-2021) 12.7.4 HENGRUI Medical PVA Foam Embolization Particles Products Offered 12.7.5 HENGRUI Medical Recent Development 12.8 INterface BIOmaterials 12.8.1 INterface BIOmaterials Corporation Information 12.8.2 INterface BIOmaterials Description and Business Overview 12.8.3 INterface BIOmaterials PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2016-2021) 12.8.4 INterface BIOmaterials PVA Foam Embolization Particles Products Offered 12.8.5 INterface BIOmaterials Recent Development 12.9 Alicon 12.9.1 Alicon Corporation Information 12.9.2 Alicon Description and Business Overview 12.9.3 Alicon PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Alicon PVA Foam Embolization Particles Products Offered 12.9.5 Alicon Recent Development 12.11 Cook Medical 12.11.1 Cook Medical Corporation Information 12.11.2 Cook Medical Description and Business Overview 12.11.3 Cook Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Cook Medical PVA Foam Embolization Particles Products Offered 12.11.5 Cook Medical Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 PVA Foam Embolization Particles Industry Trends 13.2 PVA Foam Embolization Particles Market Drivers 13.3 PVA Foam Embolization Particles Market Challenges 13.4 PVA Foam Embolization Particles Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 PVA Foam Embolization Particles Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global PVA Foam Embolization Particles Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of 50μm～350μm Table 3. Major Manufacturers of 350μm～560μm Table 4. Major Manufacturers of 560μm～710μm Table 5. Major Manufacturers of 710μm～1000μm Table 6. Major Manufacturers of 1000μm～1400μm Table 7. Major Manufacturers of 1400μm～2000μm Table 8. Global PVA Foam Embolization Particles Market Size Growth Rate by Application (2021-2027) & (K Units) Table 9. Global PVA Foam Embolization Particles Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 10. Global PVA Foam Embolization Particles Sales by Regions (2016-2021) & (K Units) Table 11. Global PVA Foam Embolization Particles Sales Market Share by Regions (2016-2021) Table 12. Global PVA Foam Embolization Particles Revenue by Regions (2016-2021) & (US$ Million) Table 13. Global PVA Foam Embolization Particles Sales Forecast by Region (2022-2027) & (K Units) Table 14. Global PVA Foam Embolization Particles Sales Market Share Forecast by Region (2022-2027) Table 15. Global PVA Foam Embolization Particles Revenue Forecast by Region (2022-2027) & (US$ Million) Table 16. Global PVA Foam Embolization Particles Revenue Market Share Forecast by Region (2022-2027) Table 17. Global PVA Foam Embolization Particles Sales by Manufacturers (2016-2021) (K Units) Table 18. Global PVA Foam Embolization Particles Sales Share by Manufacturers (2016-2021) Table 19. Ranking of Global Top PVA Foam Embolization Particles Manufacturers by Revenue (US$ Million) in 2020 Table 20. PVA Foam Embolization Particles Revenue by Manufacturers (2016-2021) (US$ Million) Table 21. PVA Foam Embolization Particles Revenue Share by Manufacturers (2016-2021) Table 22. Global PVA Foam Embolization Particles Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 23. Global PVA Foam Embolization Particles by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PVA Foam Embolization Particles as of 2020) Table 24. Key Manufacturers PVA Foam Embolization Particles Price (2016-2021) (USD/Unit) Table 25. PVA Foam Embolization Particles Manufacturers Manufacturing Base Distribution and Headquarters Table 26. Manufacturers PVA Foam Embolization Particles Product Type Table 27. Date of International Manufacturers Enter into PVA Foam Embolization Particles Market Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans Table 29. Global PVA Foam Embolization Particles Sales by Type (2016-2021) (K Units) Table 30. Global PVA Foam Embolization Particles Sales Share by Type (2016-2021) Table 31. Global PVA Foam Embolization Particles Revenue by Type (2016-2021) (US$ Million) Table 32. Global PVA Foam Embolization Particles Revenue Share by Type (2016-2021) Table 33. PVA Foam Embolization Particles Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) Table 34. Global PVA Foam Embolization Particles Sales Forecast by Type (2022-2027) & (K Units) Table 35. Global PVA Foam Embolization Particles Sales Market Share Forecast by Type (2022-2027) Table 36. Global PVA Foam Embolization Particles Revenue Forecast V (2022-2027) & (US$ Million) Table 37. Global PVA Foam Embolization Particles Revenue Market Share Forecast by Type (2022-2027) Table 38. Global PVA Foam Embolization Particles Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit) Table 39. Global PVA Foam Embolization Particles Sales by Application (2016-2021) (K Units) Table 40. Global PVA Foam Embolization Particles Sales Share by Application (2016-2021) Table 41. Global PVA Foam Embolization Particles Revenue by Application (2016-2021) (US$ Million) Table 42. Global PVA Foam Embolization Particles Revenue Share by Application (2016-2021) Table 43. PVA Foam Embolization Particles Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit) Table 44. Global PVA Foam Embolization Particles Sales Forecast by Application (2022-2027) & (K Units) Table 45. Global PVA Foam Embolization Particles Sales Market Share Forecast by Application (2022-2027) Table 46. Global PVA Foam Embolization Particles Revenue Forecast by Application (2022-2027) & (US$ Million) Table 47. Global PVA Foam Embolization Particles Revenue Market Share Forecast by Application (2022-2027) Table 48. Global PVA Foam Embolization Particles Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit) Table 49. United States PVA Foam Embolization Particles Sales (K Units) of Key Companies (2016-2021) Table 50. United States PVA Foam Embolization Particles Sales Share by Company (2016-2021) Table 51. United States PVA Foam Embolization Particles Revenue (US$ Million) by Company (2016-2021) Table 52. United States PVA Foam Embolization Particles Revenue Share by Company (2016-2021) Table 53. United States PVA Foam Embolization Particles Sales (K Units) by Type (2016-2021) Table 54. United States PVA Foam Embolization Particles Sales Share by Type (2016-2021) Table 55. United States PVA Foam Embolization Particles Revenue (US$ Million) Market Share by Type (2016-2021) Table 56. United States PVA Foam Embolization Particles Price (USD/Unit) by Type (2016-2021) Table 57. United States PVA Foam Embolization Particles Sales (K Units) by Type (2022-2027) Table 58. United States PVA Foam Embolization Particles Sales Share by Type (2022-2027) Table 59. United States PVA Foam Embolization Particles Revenue (US$ Million) Market Share by Type (2022-2027) Table 60. United States PVA Foam Embolization Particles Revenue Share by Type (2022-2027) Table 61. United States PVA Foam Embolization Particles Price (USD/Unit) by Type (2022-2027) Table 62. United States PVA Foam Embolization Particles Sales (K Units) by Application (2016-2021) Table 63. United States PVA Foam Embolization Particles Sales Share by Application (2016-2021) Table 64. United States PVA Foam Embolization Particles Revenue (US$ Million) Market Share by Application (2016-2021) Table 65. United States PVA Foam Embolization Particles Price (USD/Unit) by Application (2016-2021) Table 66. United States PVA Foam Embolization Particles Sales (K Units) by Application (2022-2027) Table 67. United States PVA Foam Embolization Particles Sales Share by Application (2022-2027) Table 68. United States PVA Foam Embolization Particles Revenue (US$ Million) Market Share by Application (2022-2027) Table 69. United States PVA Foam Embolization Particles Revenue Share by Application (2022-2027) Table 70. United States PVA Foam Embolization Particles Price (USD/Unit) by Application (2022-2027) Table 71. North America PVA Foam Embolization Particles Sales by Country (2016-2021) & (K Units) Table 72. North America PVA Foam Embolization Particles Sales Market Share by Country (2016-2021) Table 73. North America PVA Foam Embolization Particles Revenue by Country (2016-2021) & (US$ Million) Table 74. North America PVA Foam Embolization Particles Revenue Market Share by Country (2016-2021) Table 75. Asia Pacific PVA Foam Embolization Particles Sales by Region (2016-2021) & (K Units) Table 76. Asia Pacific PVA Foam Embolization Particles Sales Market Share by Region (2016-2021) Table 77. Asia Pacific PVA Foam Embolization Particles Revenue by Region (2016-2021) & (US$ Million) Table 78. Asia Pacific PVA Foam Embolization Particles Revenue Market Share by Region (2016-2021) Table 79. Europe PVA Foam Embolization Particles Sales by Country (2016-2021) & (K Units) Table 80. Europe PVA Foam Embolization Particles Sales Market Share by Country (2016-2021) Table 81. Europe PVA Foam Embolization Particles Revenue by Country (2016-2021) & (US$ Million) Table 82. Europe PVA Foam Embolization Particles Revenue Market Share by Country (2016-2021) Table 83. Latin America PVA Foam Embolization Particles Sales by Country (2016-2021) & (K Units) Table 84. Latin America PVA Foam Embolization Particles Sales Market Share by Country (2016-2021) Table 85. Latin Americaa PVA Foam Embolization Particles Revenue by Country (2016-2021) & (US$ Million) Table 86. Latin America PVA Foam Embolization Particles Revenue Market Share by Country (2016-2021) Table 87. Middle East and Africa PVA Foam Embolization Particles Sales by Country (2016-2021) & (K Units) Table 88. Middle East and Africa PVA Foam Embolization Particles Sales Market Share by Country (2016-2021) Table 89. Middle East and Africa PVA Foam Embolization Particles Revenue by Country (2016-2021) & (US$ Million) Table 90. Middle East and Africa PVA Foam Embolization Particles Revenue Market Share by Country (2016-2021) Table 91. Cook Medical Corporation Information Table 92. Cook Medical Description and Business Overview Table 93. Cook Medical PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 94. Cook Medical PVA Foam Embolization Particles Product Table 95. Cook Medical Recent Development Table 96. Sirtex Medical Corporation Information Table 97. Sirtex Medical Description and Business Overview Table 98. Sirtex Medical PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 99. Sirtex Medical Product Table 100. Sirtex Medical Recent Development Table 101. Merit Medical Corporation Information Table 102. Merit Medical Description and Business Overview Table 103. Merit Medical PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 104. Merit Medical Product Table 105. Merit Medical Recent Development Table 106. BTG Medical Corporation Information Table 107. BTG Medical Description and Business Overview Table 108. BTG Medical PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 109. BTG Medical Product Table 110. BTG Medical Recent Development Table 111. Boston Scientific Corporation Information Table 112. Boston Scientific Description and Business Overview Table 113. Boston Scientific PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 114. Boston Scientific Product Table 115. Boston Scientific Recent Development Table 116. Terumo Corporation Information Table 117. Terumo Description and Business Overview Table 118. Terumo PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 119. Terumo Product Table 120. Terumo Recent Development Table 121. HENGRUI Medical Corporation Information Table 122. HENGRUI Medical Description and Business Overview Table 123. HENGRUI Medical PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 124. HENGRUI Medical Product Table 125. HENGRUI Medical Recent Development Table 126. INterface BIOmaterials Corporation Information Table 127. INterface BIOmaterials Description and Business Overview Table 128. INterface BIOmaterials PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 129. INterface BIOmaterials Product Table 130. INterface BIOmaterials Recent Development Table 131. Alicon Corporation Information Table 132. Alicon Description and Business Overview Table 133. Alicon PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 134. Alicon Product Table 135. Alicon Recent Development Table 136. PVA Foam Embolization Particles Market Trends Table 137. PVA Foam Embolization Particles Market Drivers Table 138. PVA Foam Embolization Particles Market Challenges Table 139. PVA Foam Embolization Particles Market Restraints Table 140. PVA Foam Embolization Particles Customers List Table 141. PVA Foam Embolization Particles Distributors List Table 142. Research Programs/Design for This Report Table 143. Key Data Information from Secondary Sources Table 144. Key Data Information from Primary Sources List of Figures Figure 1. PVA Foam Embolization Particles Product Picture Figure 2. Global PVA Foam Embolization Particles Sales Market Share by Type in 2020 & 2027 Figure 3. 50μm～350μm Product Picture Figure 4. 350μm～560μm Product Picture Figure 5. 560μm～710μm Product Picture Figure 6. 710μm～1000μm Product Picture Figure 7. 1000μm～1400μm Product Picture Figure 8. 1400μm～2000μm Product Picture Figure 9. Global PVA Foam Embolization Particles Sales Market Share by Application in 2020 & 2027 Figure 10. Uterine Fibroid Embolization Figure 11. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Figure 12. Liver Tumor Embolization Figure 13. Trauma Embolization Figure 14. Others Figure 15. PVA Foam Embolization Particles Report Years Considered Figure 16. Global PVA Foam Embolization Particles Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global PVA Foam Embolization Particles Market Size 2016-2027 (US$ Million) Figure 18. Global PVA Foam Embolization Particles Sales 2016-2027 (K Units) Figure 19. Global PVA Foam Embolization Particles Market Size Market Share by Region: 2021 Versus 2027 Figure 20. Global PVA Foam Embolization Particles Sales Market Share by Region (2016-2021) Figure 21. Global PVA Foam Embolization Particles Sales Market Share by Region in 2020 Figure 22. Global PVA Foam Embolization Particles Revenue Market Share by Region (2016-2021) Figure 23. Global PVA Foam Embolization Particles Revenue Market Share by Region in 2020 Figure 24. Global PVA Foam Embolization Particles Sales Share by Manufacturer in 2020 Figure 25. The Top 10 and 5 Players Market Share by PVA Foam Embolization Particles Revenue in 2020 Figure 26. PVA Foam Embolization Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 27. Global PVA Foam Embolization Particles Sales Market Share by Type (2016-2021) Figure 28. Global PVA Foam Embolization Particles Sales Market Share by Type in 2020 Figure 29. Global PVA Foam Embolization Particles Revenue Market Share by Type (2016-2021) Figure 30. Global PVA Foam Embolization Particles Revenue Market Share by Type in 2020 Figure 31. Global PVA Foam Embolization Particles Sales Market Share by Application (2016-2021) Figure 32. Global PVA Foam Embolization Particles Sales Market Share by Application in 2020 Figure 33. Global PVA Foam Embolization Particles Revenue Market Share by Application (2016-2021) Figure 34. Global PVA Foam Embolization Particles Revenue Market Share by Application in 2020 Figure 35. United States PVA Foam Embolization Particles Sales Growth Rate 2016-2027 (K Units) Figure 36. United States PVA Foam Embolization Particles Revenue Growth Rate 2016-2027 (US$ Million) Figure 37. United States PVA Foam Embolization Particles Market Share in Global Market 2016-2027 Figure 38. United States 5 and 10 Largest PVA Foam Embolization Particles Players Market Share by Revenue in PVA Foam Embolization Particles in 2020 Figure 39. United States PVA Foam Embolization Particles Revenue Share by Type (2016-2021) Figure 40. United States PVA Foam Embolization Particles Revenue Growth Rate by Type in 2016 & 2020 Figure 41. United States PVA Foam Embolization Particles Revenue Share by Application (2016-2021) Figure 42. United States PVA Foam Embolization Particles Revenue Growth Rate by Application in 2016 & 2020 Figure 43. North America PVA Foam Embolization Particles Sales Growth Rate 2016-2021 (K Units) Figure 44. North America PVA Foam Embolization Particles Revenue Growth Rate 2016-2021 (US$ Million) Figure 45. North America PVA Foam Embolization Particles Sales Market Share by Country in 2020 Figure 46. North America PVA Foam Embolization Particles Revenue Market Share by Country in 2020 Figure 47. U.S. PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 48. U.S. PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Canada PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 50. Canada PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. Europe PVA Foam Embolization Particles Sales Growth Rate 2016-2021 (K Units) Figure 52. Europe PVA Foam Embolization Particles Revenue Growth Rate 2016-2021 (US$ Million) Figure 53. Europe PVA Foam Embolization Particles Sales Market Share by Country in 2020 Figure 54. Europe PVA Foam Embolization Particles Revenue Market Share by Country in 2020 Figure 55. Germany PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 56. Germany PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. France PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 58. France PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. U.K. PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 60. U.K. PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Italy PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 62. Italy PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 63. Russia PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 64. Russia PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Asia Pacific PVA Foam Embolization Particles Sales Growth Rate 2016-2021 (K Units) Figure 66. Asia Pacific PVA Foam Embolization Particles Revenue Growth Rate 2016-2021 (US$ Million) Figure 67. Asia Pacific PVA Foam Embolization Particles Sales Market Share by Region in 2020 Figure 68. Asia Pacific PVA Foam Embolization Particles Revenue Market Share by Region in 2020 Figure 69. China PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 70. China PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. Japan PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 72. Japan PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. South Korea PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 74. South Korea PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. India PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 76. India PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Australia PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 78. Australia PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Taiwan PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 80. Taiwan PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Indonesia PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 82. Indonesia PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Thailand PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 84. Thailand PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Malaysia PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 86. Malaysia PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Philippines PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 88. Philippines PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 89. Vietnam PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 90. Vietnam PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Latin America PVA Foam Embolization Particles Sales Growth Rate 2016-2021 (K Units) Figure 92. Latin America PVA Foam Embolization Particles Revenue Growth Rate 2016-2021 (US$ Million) Figure 93. Latin America PVA Foam Embolization Particles Sales Market Share by Country in 2020 Figure 94. Latin America PVA Foam Embolization Particles Revenue Market Share by Country in 2020 Figure 95. Mexico PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 96. Mexico PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Brazil PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 98. Brazil PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 99. Argentina PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 100. Argentina PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Middle East and Africa PVA Foam Embolization Particles Sales Growth Rate 2016-2021 (K Units) Figure 102. Middle East and Africa PVA Foam Embolization Particles Revenue Growth Rate 2016-2021 (US$ Million) Figure 103. Middle East and Africa PVA Foam Embolization Particles Sales Market Share by Country in 2020 Figure 104. Middle East and Africa PVA Foam Embolization Particles Revenue Market Share by Country in 2020 Figure 105. Turkey PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 106. Turkey PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. Saudi Arabia PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 108. Saudi Arabia PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 109. U.A.E PVA Foam Embolization Particles Sales Growth Rate (2016-2021) (K Units) Figure 110. U.A.E PVA Foam Embolization Particles Revenue Growth Rate (2016-2021) (US$ Million) Figure 111. PVA Foam Embolization Particles Value Chain Figure 112. Channels of Distribution Figure 113. Distributors Profiles Figure 114. Bottom-up and Top-down Approaches for This Report Figure 115. Data Triangulation Figure 116. Key Executives Interviewed

Cook Medical Sirtex Medical Merit Medical BTG Medical Boston Scientific Terumo HENGRUI Medical INterface BIOmaterials Alicon